Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 1

2(28.6%)

7Total

N/A(5)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03455478Not ApplicableRecruiting

Shanghai Eye Study for Adults

Role: collaborator

NCT03690414Phase 1Completed

Evaluation of Short Term Use of Experimental Eye Drops BHVI2, 0.02% Atropine and BHVI2 Plus 0.02% Atropine Eye Drops

Role: collaborator

NCT03699423Phase 1Completed

Effects of Low Concentration Atropine on Pupillary Size and Accommodative Amplitude

Role: collaborator

NCT02484586Not ApplicableCompleted

Dispensing Study to Assess the Visual Performance of Optimised Prototype Contact Lenses

Role: lead

NCT02980445Not ApplicableUnknown

Time Outdoors as an Intervention for Myopia in Children

Role: collaborator

NCT02214797Not ApplicableCompleted

Dispensing Study to Assess Visual Performance of Prototype Contact Lenses

Role: lead

NCT02193555Not ApplicableCompleted

Visual Performance of Prototype Contact Lens Designs

Role: lead

All 7 trials loaded